Expression of the 90K Immunostimulator Gene Is Controlled by a Promoter with Unique Features
Open Access
- 1 February 1997
- journal article
- Published by Elsevier
- Vol. 272 (6) , 3674-3682
- https://doi.org/10.1074/jbc.272.6.3674
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The enigma of the natural killer cellNature, 1995
- Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2Nature, 1995
- The gene (LGALS3BP) encoding the serum protein 90K, associated with cancer and infection by the human immunodeficiency virus, maps at 17q25Cytogenetic and Genome Research, 1995
- Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cellsInternational Journal of Cancer, 1994
- Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicingTrends in Genetics, 1994
- The SpliceosomeBioEssays, 1993
- Cooperative interaction of an initiator-binding transcription initiation factor and the helix–loop–helix activator USFNature, 1991
- Unusually High Level of a Tumor-Associated Antigen in the Serum of Human Immunodeficiency Virus-Seropositive IndividualsThe Journal of Infectious Diseases, 1991
- Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elementsCell, 1988
- Recombinant human leukocyte interferon‐α 2b stimulates the synthesis and release of a 90k tumor‐associated antigen in human breast cancer cellsInternational Journal of Cancer, 1988